SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
SHAC was delisted on the 9th of December, 2022.
37 hedge funds and large institutions have $100M invested in SCP & CO Healthcare Acquisition Company Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.8M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$16.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$7.21M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.88M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
+$5.81M |
Top Sellers
SHAC Hedge Fund Activity: Q1 2021 in Review
37 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) for Q1 2021, worth a combined $100M.
Buyers outnumbered sellers: 37 funds opened new SHAC positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $16.8M.
- 37 institutional investors held SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $100M of SCP & CO Healthcare Acquisition Company Class A Common Stock stock for Q1 2021.
- 37 funds opened new SCP & CO Healthcare Acquisition Company Class A Common Stock positions in Q1 2021 and 0 closed out, a net change of +37 holders.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock buyer in Q1 2021 was Balyasny Asset Management, an estimated $16.8M added.
Based on aggregated 13F filings for Q1 2021.